Company: CDT
Filing Date: 2025-04-16
Form Type: PRE 14A
Source: 0001641172-25-005096
Chunk: 0

Company: CDT Equity Inc.
Filing Date: 2025-04-16
Form: PRE 14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☒ | Preliminary                                                       
 Proxy Statement                                                   |
| ☐ | Confidential,                                                     
 For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive                                                        
 Proxy Statement                                                   |
| ☐ | Definitive                                                        
 Additional Materials                                              |
| ☐ | Soliciting                                                        
 Material Pursuant to §240.14a-12                                  |

<div align='center'>CONDUIT PHARMACEUTICALS INC.

(Name of Registrant as Specified in its Charter)

N/A

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</div>

Payment of Filing Fee (Check all boxes that apply):

| ☒ | No                                                                                               
 fee required.                                                                                    |
| ☐ | Fee                                                                                              
 paid previously with preliminary materials.                                                      |
| ☐ | Fee                                                                                              
 computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

<div align='center'>PRELIMINARY PROXY STATEMENT, SUBJECT TO COMPLETION, DATED APRIL 16, 2025

4581 Tamiami Trail North, Suite 200

Naples, Florida 34103

(646) 491-9132

NOTICE OF VIRTUAL SPECIAL MEETING OF STOCKHOLDERS

TO BE HELD ON FRIDAY, MAY 9, 2025</div>

To our stockholders:

The 2025 virtual special meeting of stockholders (the “Special Meeting”) of Conduit Pharmaceuticals Inc., a Delaware corporation, will be held on Friday, May 9, 2025, at 10:00 a.m., Eastern Time, for the following purposes:

| 1. | To                                                                                                                                
 approve one or more amendments of the Company’s Second Amended and Restated Certificate of Incorporation to effect one or more    
 reverse stock splits of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a ratio ranging